Home Events Molecular diagnostics as applies to the current practice of Hematopathology and transition from residency

Molecular diagnostics as applies to the current practice of Hematopathology and transition from residency

Date

January 14 2022

Time

1:30 pm - 2:45 pm

Speaker

  • Dr. Philip Berardi Dr. Philip Berardi
    Dr. Philip Berardi
    Dr. Philip Berardi

    Dr. Berardi completed his Hematopathology and Transfusion Medicine training in Ottawa and is now a staff Hematopathologist at the Ottawa Hospital. He holds a PhD in Biochemistry & Molecular Biology from the University of Calgary.

Description

This presentation will focus on the changing landscape of molecular diagnostic testing for hematolymphoid neoplasms.
Emphasis will be placed on best practices for interpreting molecular diagnostic tests and ways to communicate these results
to optimize patient care

Objectives

  1. Explain the principles of molecular diagnostic testing as applies to complex malignant hematology and recommend
    specimen requirements needed for accurate results.
  2. Differentiate between clinically actionable mutations and predictive markers and describe how these can influence clinical
    decision-making in routine practice.
  3. Discuss myeloid neoplasms arising in the setting of germline predisposition and adopting a strategy to managing these
    complex cases.
  4. Outline a general approach to laboratory management and quality assurance as it pertains to molecular diagnostics.

Target Audience

Residents

CanMEDS Roles

Medical Expert (the integrating role)

Register